Quality of life in advanced non-small cell lung cancer patients receiving palliative chemotherapy: A meta-analysis of randomized controlled trials

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 1, 2012-01 ,pp. : 134-140

Spandidos Publications

Access to resources Recommend Favorite

Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

By Jiang Jingwei   Huang Lizhen   Liang Xiaohua   Zhou Xinli   Huang Ruofan   Chu Zhaohui   Zhan Qiong  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 582-588

Informa Healthcare

Access to resources Recommend Favorite

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

By Cao Chao   Wang Jianmiao   Bunjhoo Hansvin   Xu Yongjian   Fang Huijuan  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite

Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis

By Liu Yu   Yin Tie-Jun   Zhou Rong   Zhou Si   Fan Liang   Zhang Rong-Ge  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1125-1132

Springer Publishing Company

Access to resources Recommend Favorite

Taking ACTION to establish direct costs and outcomes of treating advanced non-small cell lung cancer in routine clinical practice

By Cullen M.   Szczepura A.   Thomas M.   Kielhorn A.  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 113-115

Elsevier

Access to resources Recommend Favorite